Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
WEIL JOHN D
   2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC [AHPI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
200 N BROADWAY SUITE 825		 3. Date of Earliest Transaction (Month/Day/Year)
12/10/2014
(Street)

ST LOUIS, MO 63102		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/10/2014   P   700 A $ 1.43 44,182 D  
Common Stock 12/11/2014   P   10,000 A $ 1.45 54,182 D  
Common Stock               5,000 I IRA
Common Stock               188,855 I Spouse (1)
Common Stock               118,203 I Trust (2)
Common Stock               447,361 I Trust (3)
Common Stock               990,079 I Limited Partnership (4)
Common Stock               15,853 I Corporation (5)
Common Stock               239,587 I Trust (6)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) $ 1.58             11/13/2015(7) 11/13/2024 Common Stock 1,500   1,500 D  
Option (right to buy) $ 2.31             11/14/2014(7) 11/14/2023 Common Stock 1,500   1,500 D  
Option (right to buy) $ 2.59             11/08/2013(7) 11/08/2022 Common Stock 1,500   1,500 D  
Option (right to buy) $ 3.555             11/10/2012(7) 11/10/2021 Common Stock 1,500   1,500 D  
Option (right to buy) $ 4.34             11/11/2011(7) 11/11/2020 Common Stock 1,500   1,500 D  
Option (right to buy) $ 5.04             11/13/2010(7) 11/13/2019 Common Stock 1,500   1,500 D  
Option (right to buy) $ 4.05             11/13/2009(7) 11/13/2018 Common Stock 1,500   1,500 D  
Option (right to buy) $ 6.73             11/08/2008(7) 11/08/2017 Common Stock 1,500   1,500 D  
Option (right to buy) $ 5.24             11/16/2007(7) 11/16/2016 Common Stock 1,500   1,500 D  
Option (right to buy) $ 5.63             11/14/2006(7) 12/14/2015 Common Stock 1,000   1,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
WEIL JOHN D
200 N BROADWAY SUITE 825
ST LOUIS, MO 63102		   X   X    

Signatures

 John D. Weil   12/12/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reporting person disclaims any economic benefit in such shares.
(2) Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
(3) Owned by a trust for the benefit of a sibling of the reporting person and for which the reporting person acts as co-trustee. The reporting person disclaims any economic benefit in such shares.
(4) Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
(5) Owned by a corporation controlled by the reporting person.
(6) Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person and/or members of his immediate family have a beneficial or contingent remainder interest. The reporting person disclaims any economic benefit in such shares.
(7) Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.